Abstract

Increasing amounts of evidence has demonstrated that T2DM (Type 2 Diabetes Mellitus) patients have increased susceptibility to CRC (colorectal cancer). As HHEX is a recognized susceptibility gene in T2DM, this work was focused on two SNPs in HHEX, rs1111875 and rs7923837, to study their association with CRC. T2DM patients without CRC (T2DM-only, n=300), T2DM with CRC (T2DM/CRC, n=135), cancer-free controls (Control, n=570), and CRC without T2DM (CRC-only, n=642) cases were enrolled. DNA samples were extracted from the peripheral blood leukocytes of the patients and sequenced by direct sequencing. The χ2 test was used to compare categorical data. We found that in T2DM patients, rs1111875 but not the rs7923837 in HHEX gene was associated with the occurrence of CRC (p= 0.006). for rs1111875, TC/CC patients had an increased risk of CRC (p=0.019, OR=1.592, 95%CI=1.046-2.423). Moreover, our results also indicated that the two variants of HEEX gene could be risk factors for CRC in general population, independent on T2DM (p< 0.001 for rs1111875, p=0.001 for rs7923837). For rs1111875, increased risk of CRC was observed in TC or TC/CC than CC individuals (p<0.001, OR= 1.780, 95%CI= 1.385-2.287; p<0.001, OR= 1.695, 95%CI= 1.335-2.152). For rs7923837, increased CRC risk was observed in AG, GG, and AG/GG than AA individuals (p< 0.001, OR= 1.520, 95%CI= 1.200-1.924; p=0.036, OR= 1.739, 95%CI= 0.989-3.058; p< 0.001, OR= 1.540, 95%CI= 1.225-1.936). This finding highlights the potentially functional alteration with HHEX rs1111875 and rs7923837 polymorphisms may increase CRC susceptibility. Risk effects and the functional impact of these polymorphisms need further validation.

Highlights

  • Accumulated evidence has demonstrated that diabetes is a risk factor of various types of cancers such as colorectum (RR=1.3) [1], breast (RR=1.2) [2], endometrium (RR=2.1) [3], bladder (RR=1.35) [4], liver (RR=2.5) [5], and pancreas (RR=1.94) [6] cancer

  • Our results indicated that the two variants of HEEX gene could be risk factors for colorectal cancer (CRC) in general population, independent on Type 2 diabetes mellitus (T2DM) (p< 0.001 for rs1111875, p=0.001 for rs7923837)

  • Similar to the previous reported research, we found that the CRC risk in T2DM patients was about 1.3 times higher than that in non-Diabetes Mellitus (DM) control (p=0.00282, OR=1.3097, 95%CI =1.097-1.564), Table 1

Read more

Summary

Introduction

Accumulated evidence has demonstrated that diabetes is a risk factor of various types of cancers such as colorectum (RR=1.3) [1], breast (RR=1.2) [2], endometrium (RR=2.1) [3], bladder (RR=1.35) [4], liver (RR=2.5) [5], and pancreas (RR=1.94) [6] cancer. Type 2 diabetes mellitus (T2DM) have threaten more than 200 million individuals worldwide and its prevalence continues to increasing in many countries including China. The precise mechanisms underlying the development and progression of T2DM have not been elucidated, hereditary factors have been known to contribute to the T2DM. The firstdegree relatives of T2DM patients have ~3.5 times the risk of T2DM compared to individuals in the general population [10, 11]. Whether hereditary factors of T2DM contribute to the risk of colorectal cancer is still unknown. It is unclear whether those factors worsen the prognosis of T2DM

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call